Tags |
|
|
Links |
|
|
Main Subject - The Professor Makes A Minus Power Move
If you think the power move has costs, consider the alternative. We are talking -- four friends -- bringing one another up to date on our personal and professional lives.
David is department chair at the university; he is depressed. “Bummed out,” he
David is department chair at the university; he is depressed. “Bummed out,” he
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
says. “I find myself withdrawing, caring less and less about the department, the school.”
We are stunned; just a month ago David was so enthusiastic about the possibilities he saw for creating a dynamic department. This is a man who deeply cares ab
We are stunned; just a month ago David was so enthusiastic about the possibilities he saw for creating a dynamic department. This is a man who deeply cares ab
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ut relationships and family and here was his chance, as department chair, to create a caring professional community. He had just overseen a series of interviews with a promising candidate. “She is terrific, she has great energy, her research work is
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
olid, and I think she impressed everyone she met.” This was to be an important beginning, and David was charged up.
“So what happened?” we ask. “The Dean,” says David with considerable disgust. “The Dean said he’d support her appointment, but not
“So what happened?” we ask. “The Dean,” says David with considerable disgust. “The Dean said he’d support her appointment, but not
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
with tenure. And without tenure we weren’t going to get her. Without the Dean’s support it just wasn’t going to happen. So we lost her.”
We then drifted into a conversation about the Dean, his personal deficiencies, his weak leadership, his visi
We then drifted into a conversation about the Dean, his personal deficiencies, his weak leadership, his visi
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
n for the school (which was never anyone else’s vision), and particularly about his aversion to diversity issues and women’s studies, the rejected candidate’s research areas. “He’s a chauvinistic pig,” says David, “all that feminist stuff makes him n
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
rvous.” Then the conversation gets into speculation as to how much longer the dean will be around, what his employment prospects are.
And so the hope for departmental salvation appears to lie in waiting for the Dean’s retirement.
At this point Max
And so the hope for departmental salvation appears to lie in waiting for the Dean’s retirement.
At this point Max
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
peaks up. “I can’t believe this conversation. Your most powerful strategy is to sit here fantasizing about when the dean will leave. What about power? I looked at the listing of the nation’s top one hundred schools, and yours was nowhere to be seen.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
hat does that say about the Dean’s leadership? And does that poor showing give you some leverage?”
Max then looks at Dan. “The same thing happened to you. What was it, ten years ago? They screwed you on tenure, and you just walked away with your tai
Max then looks at Dan. “The same thing happened to you. What was it, ten years ago? They screwed you on tenure, and you just walked away with your tai
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
between your legs.”
Dan recalls a dream he had at the time. “I was leading a protest march; there was this army of students and faculty behind me.” “Sure,” says Max, “but that was your dream; in the wide-awake world you just walked away.” Where is
Dan recalls a dream he had at the time. “I was leading a protest march; there was this army of students and faculty behind me.” “Sure,” says Max, “but that was your dream; in the wide-awake world you just walked away.” Where is
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ower?
Dan has a thought about that question. “You know,” he says to David, “You could have resigned the chairmanship, or at least threatened to. You could have said to the Dean, “I’m department chair, and it’s my judgment that this candidate with te
Dan has a thought about that question. “You know,” he says to David, “You could have resigned the chairmanship, or at least threatened to. You could have said to the Dean, “I’m department chair, and it’s my judgment that this candidate with te
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
nure is just what the department needs. If you are not going to support my judgment on this, then I’m afraid I’ll just have to resign.”
The conversation at this point becomess more electric. What might such a move have accomplished? Maybe nothing. “
The conversation at this point becomess more electric. What might such a move have accomplished? Maybe nothing. “
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
orry to see you go,” says the Dean. But maybe it gets the Dean to think; it certainly makes clear the strength of David’s commitment. And his resignation would cause some difficulties for the Dean.
David is thoughtful. Dan’s notion has much appeal,
David is thoughtful. Dan’s notion has much appeal,
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
i>and it is frightening (a combination that inevitably accompanies the emergence of a power move.) “I would have been all alone on this; there would have been no faculty support, we are just too diffuse.” “Maybe,” says Max, “but maybe that’s just
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
the kind of leadership move that would have mobilized the faculty.” David nods in agreement.
Dan says, “And look at the costs of not making that move. You’re depressed; all your enthusiasm for energizing the department is gone; the faculty re
Dan says, “And look at the costs of not making that move. You’re depressed; all your enthusiasm for energizing the department is gone; the faculty re
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ains diffused; and you lost a damn good candidate. Meanwhile the Dean comes away unscathed.”
David continues to be deep in thought. “You know what strikes me,” he says, “the move never entered my mind. It’s not like I thought about it and rejected i
David continues to be deep in thought. “You know what strikes me,” he says, “the move never entered my mind. It’s not like I thought about it and rejected i
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
; I just never saw it.”
***
Limit Situations (Reference to Paolo Freire's Pedagogy of the Oppressed.
I just never saw it. David’s illumination gets to the heart of the limit situation. It is not some clear challenge th
***
Limit Situations (Reference to Paolo Freire's Pedagogy of the Oppressed.
I just never saw it. David’s illumination gets to the heart of the limit situation. It is not some clear challenge th
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
t the actor faces and then chooses to take on or not. It is rather an option that is invisible to the actor. At the point of the limit situation, the actor sees no choice. The Dean’s “No” is the end, in Vieira Pinto’s words (cited by Freire), the “im
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
assable barrier.” It is “the given.” It is only with a flash of insight, or a working through of one’s depression, anger or anxiety, or, as in this case, through dialogue, that the invisible becomes visible, that one can “negate and overcome the gi
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
en” (Freire’s words), that “impassable boundaries where possibilities end” become “real boundaries where all possibilities begin.”
Strangely,the clues to opportunities for power lie in those moments when we are feeling angry, hopeless, and powerless
Strangely,the clues to opportunities for power lie in those moments when we are feeling angry, hopeless, and powerless
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24455/mainsubjects-The-Professor-Makes-A-Minus-Power-Move.html">The Professor Makes A Minus Power Move</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24455/mainsubjects-The-Professor-Makes-A-Minus-Power-Move.html]The Professor Makes A Minus Power Move[/url]
Related Articles:
How To Gain The Admiration of Your Employer
Building Your Dream Franchise Business
Questions To Ask Employees You Want To Retain
Bookmark it:
|